Projects per year
Personal profile
Areas of expertise
External responsibilities
Diplomas
Areas of expertise
External responsibilities
Diplomas
Education/Academic qualification
Doctor of Pharmacy, Thesis Drug design and developpment, Université de Liège
Award Date: 30 Jun 2000
Fingerprint
Dive into the research topics where Jean-Michel Dogné is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
MP-EMA: Belgian representation on the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) 2024-2027
Dogné, J.-M. (PI)
1/07/24 → 30/07/27
Project: Research
-
Management of (activated) factor eleven (FXI(a)) inhibitors
Vassart, J. (Researcher), Douxfils, J. (PI) & Dogné, J.-M. (Co-supervisor)
17/10/22 → …
Project: PHD
-
Clinical Pharmacology Research Group
Douxfils, J. (Supervisor), Dogné, J.-M. (Supervisor), Musuamba Tshinanu, F. (Supervisor), Masereel, B. (Supervisor), Wieërs, G. (Supervisor), Haguet, H. (Researcher), RONVAUX, L. (Researcher), Donis, N. (Researcher), Morimont, L. (Researcher), Evrard, J. (Researcher), Siriez, R. (Researcher), Gillot, C. (Researcher), Favresse, J. (Researcher), BOUVY, C. (Researcher), Djokoto, H. (Researcher), Didembourg, M. (Researcher), David, C. (Support role), Melchionda, S. (Support role), Maloteau, V. (Technician), Boucher, A.-Y. (Technician), Devel, P. (Technician), Modaffari, E. (Technician), Vandeputte, M. (Technician), De Messemaeker, A. (Secretaire), Decarpentrie, J. (Researcher), Vassart, J. (Researcher) & De Groote, A. (Researcher)
1/04/22 → …
Project: Research Axis
-
The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J. (Supervisor), Dogné, J.-M. (Co-supervisor), Favresse, J. (CoI), Tre-Hardy, M. (CoI), Mullier, F. (CoI), Haguet, H. (Researcher), Hardy, M. (Researcher), Melchionda, S. (Researcher), BOUVY, C. (Researcher), Morimont, L. (Researcher), Gillot, C. (Researcher), Djokoto, H. (Researcher), Alpan, L. (Technician), Devel, P. (Technician), Modaffari, E. (Technician) & Maloteau, V. (Technician)
13/03/20 → …
Project: Research
-
The CAF project - a new tool for the assessment of the clot formation
Douxfils, J. (Supervisor), Dogné, J.-M. (CoI), Evrard, J. (Researcher), Morimont, L. (Researcher) & Maloteau, V. (Technician)
1/09/18 → …
Project: Research
-
Frequently reported blood biomarkers in sarcopenia clinical trials: a systematic review and meta-analysis.
Calluy, E., Boretti, E., Malrechauffe, Y., Van heden, S., Sanchez-Rodriguez, D., Chan, Y. M., Ladang, A., Cavalier, E., Dogné, J.-M., Douxfils, J. & Beaudart, C., 2025.Research output: Contribution to conference › Abstract › peer-review
-
Frequently reported blood biomarkers in sarcopenia clinical trials: a systematic review and meta-analysis.
Calluy, E., Boretti, E., Malrechauffe, Y., Van Heden, S., Sanchez-Rodriguez, D., Chan, Y. M., Ladang, A., Cavalier, E., Dogné, J.-M., Douxfils, J. & Beaudart, C., 2025.Research output: Contribution to conference › Poster › peer-review
-
Hydroxychloroquine use during the first COVID-19 wave: a case study highlighting the urgent need to enhance research practices within the publication ecosystem
Beaudart, C., Musuamba, F., Locquet, M., Dogné, J. M. & Douxfils, J., Dec 2025, In: Archives of Public Health. 83, 1, 115.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of asundexian on a panel of coagulation assays
Vassart, J., Ndzatou, D. B., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Demeure, F., Lebreton, A., Mullier, F., Favresse, J., Hardy, M., Dogné, J.-M. & Douxfils, J., Jul 2025, In: Research and Practice in Thrombosis and Haemostasis. 9, 5, p. 102950 102950.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Letter to the Editor Regarding: Safety of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies
Douxfils, J., Boretti, E., Beaudart, C. & Dogné, J.-M., Aug 2025, In: Advances in Therapy. 42, 8, p. 4089-4091 3 p.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
CCDC 1017214: Experimental Crystal Structure Determination
Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J.-M. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J.-L. (Contributor), Pirotte, B. (Contributor), Renard, J.-F. (Contributor) & WINUM, J.-Y. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014
DOI: 10.5517/cc134hc3, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cc134hc3&sid=DataCite
Dataset
-
Clustering and kernel density estimation for assessment of measurable residual disease by flow cytometry
Jacqmin, H. (Contributor), Chatelain, B. (Contributor), Louveaux, Q. (Contributor), Jacqmin, P. (Contributor), Dogné, J.-M. (Contributor), Graux, C. (Contributor) & Mullier, F. (Contributor), Zenodo, 18 May 2020
Dataset
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
-
CCDC 1017215: Experimental Crystal Structure Determination
Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J.-M. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J.-L. (Contributor), Pirotte, B. (Contributor), Renard, J.-F. (Contributor) & WINUM, J.-Y. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014
DOI: 10.5517/cc134hd4, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cc134hd4&sid=DataCite
Dataset
Prizes
-
Prix Léo Pharma Cancer & Thrombosis
Haguet, H. (Recipient), Douxfils, J. (Recipient), Mullier, F. (Recipient) & Dogne, J.-M. (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities
- 7 Oral presentation
-
Credibility assessment of model informed drug development approaches in paediatric and rare diseases: a review of EMA submissions and assessment reports from 2014 to 2024
Musuamba Tshinanu, F. (Speaker), Haguet, H. (Speaker), Hanquet, L. (Speaker), Dionisi, M. (Speaker), Govere, G. S. (Speaker), Djokoto, H. (Speaker), Massaux, C. (Speaker) & Dogné, J.-M. (Speaker)
Jun 2025Activity: Talk or presentation types › Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
Press/Media
-
New COVID-19 Research from Universite de Namur Described (Hydroxychloroquine use during the first COVID-19 wave: a case study highlighting the urgent need to enhance research practices within the publication ecosystem)
Dogné, J.-M., Douxfils, J., Musuamba Tshinanu, F., Beaudart, C. & Locquet, M.
12/05/25
1 item of Media coverage
Press/Media: Expert Comment
-
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
11/04/25
2 items of Media coverage
Press/Media: Expert Comment
-
Minutes of the PRAC meeting 28-31 October 2024
15/01/25
1 item of Media coverage
Press/Media: Expert Comment
-
PRAC recommendations on signals adopted at the 28-31 October 2024 PRAC meeting
25/11/24
1 item of Media coverage
Press/Media: Expert Comment
-
University of Namur Reports Findings in Oral Contraceptives (Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: A disproportionality analysis ...)
Dogné, J.-M., Douxfils, J., Beaudart, C., Locquet, M. & Didembourg, M.
20/11/24
1 item of Media coverage
Press/Media: Expert Comment